Proteomic reference map for sarcopenia research: mass spectrometric identification of key muscle proteins located in the sarcomere, cytoskeleton and the extracellular matrix

Sarcopenia of old age is characterized by the progressive loss of skeletal muscle mass and concomitant decrease in contractile strength. Age-related skeletal muscle dysfunctions play a key pathophysiological role in the frailty syndrome and can result in a drastically diminished quality of life in t...

Full description

Bibliographic Details
Published in:	European Journal of Translational Myology
Main Authors:	Paul Dowling, Stephen Gargan, Margit Zweyer, Michael Henry, Paula Meleady, Dieter Swandulla, Kay Ohlendieck
Format:	Article
Language:	English
Published:	PAGEPress Publications 2024-05-01
Subjects:	Aging mass spectrometry muscle proteomics muscular dystrophy
Online Access:	https://www.pagepressjournals.org/bam/article/view/12564

Similar Items

Mass Spectrometric Profiling of Extraocular Muscle and Proteomic Adaptations in the <i>mdx-4cv</i> Model of Duchenne Muscular Dystrophy
by: Stephen Gargan, et al.
Published: (2021-06-01)

Proteomic reference map for sarcopenia research: mass spectrometric identification of key muscle proteins of organelles, cellular signaling, bioenergetic metabolism and molecular chaperoning
by: Paul Dowling, et al.
Published: (2024-05-01)

Concurrent Label-Free Mass Spectrometric Analysis of Dystrophin Isoform Dp427 and the Myofibrosis Marker Collagen in Crude Extracts from mdx-4cv Skeletal Muscles
by: Sandra Murphy, et al.
Published: (2015-09-01)

Extracellular Matrix Proteomics: The <i>mdx-4cv</i> Mouse Diaphragm as a Surrogate for Studying Myofibrosis in Dystrophinopathy
by: Paul Dowling, et al.
Published: (2023-07-01)

Proteomic Identification of Markers of Membrane Repair, Regeneration and Fibrosis in the Aged and Dystrophic Diaphragm
by: Stephen Gargan, et al.
Published: (2022-10-01)

Mass Spectrometry-Based Proteomic Technology and Its Application to Study Skeletal Muscle Cell Biology
by: Paul Dowling, et al.
Published: (2023-11-01)

Universal Proteomic Signature After Exercise‐Induced Muscle Injury in Muscular Dystrophies
by: Mads G. Stemmerik, et al.
Published: (2025-05-01)

Comparative Label-Free Mass Spectrometric Analysis of Mildly versus Severely Affected mdx Mouse Skeletal Muscles Identifies Annexin, Lamin, and Vimentin as Universal Dystrophic Markers
by: Ashling Holland, et al.
Published: (2015-06-01)

Serum protein biomarker signature of Duchenne muscular dystrophy
by: Paul Dowling, et al.
Published: (2025-05-01)

Simultaneous Pathoproteomic Evaluation of the Dystrophin-Glycoprotein Complex and Secondary Changes in the mdx-4cv Mouse Model of Duchenne Muscular Dystrophy
by: Sandra Murphy, et al.
Published: (2015-06-01)

Comparative proteomic analyses of Duchenne muscular dystrophy and Becker muscular dystrophy muscles: changes contributing to preserve muscle function in Becker muscular dystrophy patients
by: Daniele Capitanio, et al.
Published: (2020-04-01)

How Can Proteomics Help to Elucidate the Pathophysiological Crosstalk in Muscular Dystrophy and Associated Multi-System Dysfunction?
by: Paul Dowling, et al.
Published: (2024-01-01)

The Dystrophin Node as Integrator of Cytoskeletal Organization, Lateral Force Transmission, Fiber Stability and Cellular Signaling in Skeletal Muscle
by: Paul Dowling, et al.
Published: (2021-02-01)

Tracking disease progression non‐invasively in Duchenne and Becker muscular dystrophies
by: Pietro Spitali, et al.
Published: (2018-08-01)

Translocation of molecular chaperones to the titin springs is common in skeletal myopathy patients and affects sarcomere function
by: Andreas Unger, et al.
Published: (2017-09-01)

Proteomic identification of elevated saliva kallikrein levels in the mdx-4cv mouse model of Duchenne muscular dystrophy
by: Sandra Murphy, et al.
Published: (2019-07-01)

Contrasting Becker and Duchenne muscular dystrophy serum biomarker candidates by using data independent acquisition LC-MS/MS
by: Camilla Johansson, et al.
Published: (2025-06-01)

Duchenne muscular dystrophy: an historical treatment review
by: Lineu Cesar Werneck, et al.

Subproteomic profiling of sarcolemma from dystrophic mdx-4cv skeletal muscle
by: Sandra Murphy, et al.
Published: (2018-04-01)

Muscle Proteome Analysis of Facioscapulohumeral Dystrophy Patients Reveals a Metabolic Rewiring Promoting Oxidative/Reductive Stress Contributing to the Loss of Muscle Function
by: Manuela Moriggi, et al.
Published: (2024-11-01)

The association of hand grip strength with functional measures in non-ambulatory children with Duchenne muscular dystrophy
by: Numan Bulut, et al.
Published: (2019-12-01)

A rare case of dystrophinopathy: Duchenne muscular dystrophy–Becker muscular dystrophy intermediate complex
by: Rachna Gulati, et al.
Published: (2022-01-01)

Case report of a child with combined genetic pathology: cystic fibrosis and facioscapulohumeral progressive muscular dystrophy
by: O. A. Klochkova, et al.
Published: (2015-02-01)

Multi-omics analysis of sarcospan overexpression in mdx skeletal muscle reveals compensatory remodeling of cytoskeleton-matrix interactions that promote mechanotransduction pathways
by: Jackie L. McCourt, et al.
Published: (2023-01-01)

Diagnosis of Congenital Muscular Dystrophy
by: J Gordon Millichap
Published: (1996-04-01)

P2X7 Receptor Antagonist Reduces Fibrosis and Inflammation in a Mouse Model of Alpha-Sarcoglycan Muscular Dystrophy
by: Lizzia Raffaghello, et al.
Published: (2022-01-01)

Affinity proteomics within rare diseases: a BIO‐NMD study for blood biomarkers of muscular dystrophies
by: Burcu Ayoglu, et al.
Published: (2014-06-01)

Proteomic profiling of the brain from the <i>wobbler</i> mouse model of amyotrophic lateral sclerosis reveals elevated levels of the astrogliosis marker glial fibrillary acidic protein
by: Sandra Murphy, et al.
Published: (2023-08-01)

Identification of immune-related features involved in Duchenne muscular dystrophy: A bidirectional transcriptome and proteome-driven analysis
by: Xuan Wu, et al.
Published: (2022-11-01)

ARC‐18 Improved Motor Performance Through Inhibiting ACLY‐Mediated Smad2/3 Acetylation in a Model of Duchenne Muscular Dystrophy
by: Chongyang Chen, et al.
Published: (2025-10-01)

Duchenne muscular dystrophy - disease characterization and emergent genetic therapy - literature review
by: Anna Teresa Michalska, et al.
Published: (2025-07-01)

Regional anesthesia and muscle-wasting diseases in pediatrics: A focused educational review
by: Amr Elhamrawy, et al.
Published: (2025-01-01)

Limb-girdle muscular dystrophy in Brazilian children: clinical, histological and molecular characterization
by: Marco A. Veloso Albuquerque
Published: (2014-06-01)

Cardiac Complications of Fukuyama-Type Congenital Muscular Dystrophy
by: J Gordon Millichap
Published: (2006-07-01)

A novel biomarker of fibrofatty replacement in dystrophinopathies identified by integrating transcriptome, magnetic resonance imaging, and pathology data
by: Zhihao Xie, et al.
Published: (2024-02-01)

Molecular targets to treat muscular dystrophies
by: Jochen Kinter, et al.
Published: (2014-02-01)

The FDA has approved the first gene therapy for the treatment of Duchennel's muscular dystrophy
by: article Editorial
Published: (2023-08-01)

Orthopaedic Management in Duchenne Muscular Dystrophy
by: Uma Balachandran, BA, et al.
Published: (2025-02-01)

Rather mild phenotype in a patient with homozygous null mutations in the a-sarcoglycan gene
by: M Gasperini, et al.
Published: (2006-02-01)

Inducible Heat Shock Protein 70 Levels in Patients and the mdx Mouse Affirm Regulation during Skeletal Muscle Regeneration in Muscular Dystrophy
by: Gwenny Cosemans, et al.
Published: (2022-07-01)